These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5456521)
1. CIBA. Keeping pace along a broad front. J Am Pharm Assoc; 1970 Sep; 10(9):525-7. PubMed ID: 5456521 [No Abstract] [Full Text] [Related]
2. [The pharmaceutical market: a second front]. MMW Munch Med Wochenschr; 1978 Mar; 120(9):264. PubMed ID: 306049 [No Abstract] [Full Text] [Related]
3. [Round table on the "norms for good drug compounding"]. Boll Chim Farm; 1970 Nov; 109(11):635-52. PubMed ID: 5515584 [No Abstract] [Full Text] [Related]
4. When does compounding become manufacturing? Gushee J J Am Vet Med Assoc; 1994 Jul; 205(2):235-6. PubMed ID: 7928585 [No Abstract] [Full Text] [Related]
5. [Domumentation Committee for Practical Pharmacy; accountability of research and compounding in the pharmacy]. Pharm Weekbl; 1966 Aug; 101(34):715-21. PubMed ID: 5917179 [No Abstract] [Full Text] [Related]
6. [The "third party" in the pharmaceutical industry]. Karrer E Boll Chim Farm; 1966 Aug; 105(8):563-9. PubMed ID: 6003361 [No Abstract] [Full Text] [Related]
7. [Quality control in the pharmaceutical industry]. Sloot HA Pharm Weekbl; 1968 Apr; 103(17):506-16. PubMed ID: 5665061 [No Abstract] [Full Text] [Related]
8. Drug safety: the viewpoint of the pharmaceutical manufacturing industry. Wigle WW Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099 [No Abstract] [Full Text] [Related]
9. [Evolution of manufacturing conditions and facilities in the pharmaceutical industry]. Lhoest W J Pharm Belg; 2005; 60(4):109-16. PubMed ID: 16429832 [No Abstract] [Full Text] [Related]
10. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry. Wallhäusser KH J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623 [No Abstract] [Full Text] [Related]
11. Counterfeit drugs. Bull World Health Organ; 1993; 71(3-4):464-6, 468-70. PubMed ID: 8324864 [No Abstract] [Full Text] [Related]
12. Pharmaceutical controls for drug availability. Bethel RF Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040 [No Abstract] [Full Text] [Related]
13. Foreign drug firm pleads guilty to felony charges. Lewis C FDA Consum; 2002; 36(1):35. PubMed ID: 11881596 [No Abstract] [Full Text] [Related]
14. Assaying for trace contaminants in drugs. Frediani HA Bull Parenter Drug Assoc; 1966; 20(6):189-92. PubMed ID: 5956956 [No Abstract] [Full Text] [Related]
15. The biotech drug market. Lawrence S Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645 [No Abstract] [Full Text] [Related]
16. Panel discussion: in process control and inspection for quality assurance. 3. Brofazi FR Bull Parenter Drug Assoc; 1968; 22(2):90-6. PubMed ID: 5649572 [No Abstract] [Full Text] [Related]
17. [Prospects of the Italian pharmaceutical industry in the light of American experience]. Silvestrini B Boll Chim Farm; 1966 Jul; 105(7):477-80. PubMed ID: 6003404 [No Abstract] [Full Text] [Related]
18. AUTOMATION OF DRAGEE PRODUCTION. RIECKMANN P Drugs Made Ger; 1963 Sep; 6():162-4. PubMed ID: 14060946 [No Abstract] [Full Text] [Related]
19. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms]. Stassen T; Piette M; Kinget R; Delattre L J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341 [No Abstract] [Full Text] [Related]
20. Current good manufacturing practices for PET drug products in the United States. Swanson D; Graham M; Heinonen TM; Libby P; Mills GQ J Nucl Med; 2009 Aug; 50(8):26N-8N. PubMed ID: 19652213 [No Abstract] [Full Text] [Related] [Next] [New Search]